Ivonescimab Tops Pembro in Advanced PD-L1-Positive NSCLC
First-line treatment with ivonescimab led to a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with pembrolizumab...
First-line treatment with ivonescimab led to a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with pembrolizumab...
The biggest considerations in picking shoes for most parents is that they're not too tight or too loose. Cost was...